What is the current Pediatric Vaccines market size?

The Pediatric Vaccines market size is approximately USD 24.8 billion as of 2022.

What is the expected growth forecast for the Pediatric Vaccines market?

The market is expected to grow at a CAGR of 10.8% from 2023 to 2028.

What are the key drivers of the Pediatric Vaccines market?

Increasing disease prevalence and government initiatives drive the Pediatric Vaccines market.

What are the major challenges facing the Pediatric Vaccines market?

Vaccine hesitancy and supply chain disruptions are significant challenges.

Which regions are the leaders in the Pediatric Vaccines market?

North America and Europe are the leading regions in the Pediatric Vaccines market.

Who are the top companies in the Pediatric Vaccines market?

Pfizer, GSK, and Merck are among the top companies in the Pediatric Vaccines market.

What are the future opportunities in the Pediatric Vaccines market?

Emerging markets and innovative vaccine technologies present future opportunities.

How does technology impact the Pediatric Vaccines market?

Advances in vaccine technology improve efficacy and safety.

What is the current regulatory landscape for the Pediatric Vaccines market?

Stringent regulations and approvals from authorities like FDA and EMA govern the market.

What is the future outlook for the Pediatric Vaccines market?

The future outlook is positive, driven by increasing demand and innovations.

Pediatric Vaccines Market 2026: Primary Research + Expert Analysis

Pediatric Vaccines by Application (Newborn, Infant, Child, Dolescent), by Types (Diphtheria, Influenza, Hepatitis, Pneumococcal Diseases, Meningococcal Diseases, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $12.6 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Pediatric Vaccines Market Overview

The Pediatric Vaccines market refers to the global industry focused on the development, production, and distribution of vaccines for children. As a crucial aspect of preventive healthcare, the Pediatric Vaccines market size is estimated to be around $43.7 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 10.5% from 2026 to 2033, driven by increasing demand for vaccination programs and advancements in vaccine technology, contributing to the overall industry expansion. The scope of this market encompasses various vaccine types, including inactivated, live attenuated, and conjugate vaccines, among others.

Loading chart…

Key forces shaping the Pediatric Vaccines industry include technological advancements in vaccine development, stringent regulations ensuring vaccine safety and efficacy, and changing consumer behavior towards preventive healthcare. The largest region in the Pediatric Vaccines market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and government initiatives to improve vaccination coverage. As the market continues to evolve, understanding these dynamics will be crucial for stakeholders to navigate the complex landscape of the Pediatric Vaccines market effectively.

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	27.40 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GlaxoSmithKline; Merck; Pfizer; Sanofi; AstraZeneca; Novartis; Takeda Pharmaceutical; Bavarian Nordic; Baxter; LG Life Sciences; Lupin; S K Chemicals; Mitsubishi Tanabe Pharma; Janssen; Shenzhen Kangtai Biological Products; Sinovac Biotech; Bharat Biotech; Crucell; Dynavax; Serum Institute of India
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pediatric Vaccines market is poised for significant growth, driven by increasing awareness of the importance of vaccination and advancements in vaccine technology. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in vaccine technology, such as the development of conjugate vaccines and combination vaccines, are driving the Pediatric Vaccines market size by providing improved protection against multiple diseases with fewer doses, enhancing vaccine efficacy and safety.

Government initiatives and growth forecast predictions indicate a rise in vaccination programs, particularly in developing countries, which is anticipated to boost the demand for pediatric vaccines and contribute to the market's expansion.

Restraints2 items

Stringent regulatory requirements and high development costs for new vaccines can hinder the entry of new players into the Pediatric Vaccines market, potentially limiting market growth and innovation.

Vaccine hesitancy and misinformation about vaccine safety can lead to decreased vaccination rates, negatively impacting the Pediatric Vaccines market size and public health outcomes.

Opportunities2 items

The emerging markets in Asia and Africa present significant opportunities for the Pediatric Vaccines market due to their large and growing populations, increasing healthcare expenditure, and expanding vaccination programs.

The development of novel vaccine delivery systems, such as needle-free injections, can enhance the user experience and improve vaccination rates, offering a potential area of growth for manufacturers in the Pediatric Vaccines market.

Challenges2 items

Ensuring a stable and reliable supply chain for vaccines, particularly in resource-poor settings, is a significant challenge that can impact the Pediatric Vaccines market and hinder the achievement of public health goals.

The growth forecast of the Pediatric Vaccines market can be affected by macroeconomic factors, including economic downturns and trade policies, which can influence healthcare spending and vaccine procurement.

Market Segmentation

Loading chart…

The Application segment of the Pediatric Vaccines market refers to the various uses of vaccines in preventing diseases in children. This segment is crucial in determining the overall size of the Pediatric Vaccines market, as it directly influences the demand for specific vaccines. Pediatric Vaccines segmentation by application can be further divided into subtypes, including routine vaccination, travel vaccination, and cancer vaccination, among others.

The Types segment of the Pediatric Vaccines market categorizes vaccines based on their composition, mechanism of action, or target disease. This segment is vital in understanding the Pediatric Vaccines market taxonomy, as different types of vaccines have varying market sizes and growth prospects. For instance, conjugate vaccines, inactivated vaccines, and live attenuated vaccines are common subtypes, each contributing to the overall Pediatric Vaccines market size in distinct ways.

Pediatric Vaccines Segmentation Breakdown12 items

Application

Newborn

Infant

Child

Dolescent

Types

Diphtheria

Influenza

Hepatitis

Pneumococcal Diseases

Meningococcal Diseases

Others

Regional Insights

Loading chart…

The Pediatric Vaccines market growth is anticipated to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, driven by high birth rates, government initiatives, and increasing adoption of vaccines. The fastest-growing region is expected to be Latin America, driven by expanding healthcare infrastructure, rising investments in vaccine development, and growing awareness about pediatric vaccines.

In North America, key drivers include established healthcare infrastructure, high vaccination rates, and ongoing research in vaccine development, contributing to a regional forecast of moderate growth. Europe is driven by strict vaccination policies, mature ecosystem, and significant investments in vaccine research, resulting in a steady market growth. The Asia Pacific region is driven by large population, growing demand for vaccines, and increasing government support, contributing to its position as the largest region. Latin America's growth is driven by improving healthcare infrastructure, growing awareness about pediatric vaccines, and expanding investments in vaccine development. The Middle East & Africa region is driven by government initiatives, rising adoption of vaccines, and growing demand for pediatric vaccines, although at a slower pace compared to other regions.

Competitive Landscape

The Pediatric Vaccines market is moderately consolidated, with a mix of global players and local companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Pediatric Vaccines competitive landscape is driven by global players, with key companies focusing on product innovation and regional expansion to maintain their market position. The market is characterized by high competition, with companies employing various strategies to differentiate themselves and gain market share.

Common strategies employed by companies in the Pediatric Vaccines market include M&A, partnerships, product launches, expansion, R&D, and localization. Companies are also focusing on competitive differentiation through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. Key players are adapting to these challenges by adjusting their strategies and focusing on specific areas such as innovation pipeline, local manufacturing, and premium pricing.

GlaxoSmithKline: regional expansion

Merck: innovation pipeline

Pfizer: premium pricing

Sanofi: local manufacturing

AstraZeneca: OEM tie-ups

Novartis: vertical integration

Key Pediatric Vaccines Companies20 items

GlaxoSmithKline

Merck

Pfizer

Sanofi

AstraZeneca

Novartis

Takeda Pharmaceutical

Bavarian Nordic

Baxter

LG Life Sciences

Lupin

S K Chemicals

Mitsubishi Tanabe Pharma

Janssen

Shenzhen Kangtai Biological Products

Sinovac Biotech

Bharat Biotech

Crucell

Dynavax

Serum Institute of India

Market Ecosystem

The Pediatric Vaccines ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of vaccines, with each segment influencing the overall efficiency and effectiveness of the ecosystem. A thorough value chain analysis is essential to understanding the complex interactions within the Pediatric Vaccines ecosystem.

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing vaccines

Distributors / channel partners — delivering vaccines to healthcare providers

Service providers / after-sales — offering vaccine administration and support

End users / buyers — healthcare providers and parents

Regulators/standards bodies — establishing vaccine safety and efficacy standards

Data/analytics providers — tracking vaccine effectiveness and epidemiological trends

The flow of value within the Pediatric Vaccines ecosystem is influenced by various control points, including regulatory approvals, manufacturing capacity, and distribution networks. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of vaccines. Switching costs, partnerships, and interoperability requirements can also affect the ecosystem's dynamics. Furthermore, regional differences in healthcare infrastructure, vaccine financing, and epidemiological priorities can lead to variations in the Pediatric Vaccines ecosystem across different regions.

Recent Industry Insights

The Pediatric Vaccines market has witnessed significant developments over the last 12-18 months, shaping the future of Pediatric Vaccines industry trends. Recent partnerships between pharmaceutical companies and research institutions have accelerated the development of new vaccines, while mergers and acquisitions have led to the consolidation of resources and expertise. Notable product launches have also expanded the portfolio of available vaccines, providing improved protection against infectious diseases. Furthermore, regulatory changes have facilitated the approval and distribution of vaccines, ensuring timely access to these critical healthcare products. A shift in consumer trends towards preventive care has also driven demand for pediatric vaccines, with many parents seeking to protect their children from vaccine-preventable diseases.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Pediatric Vaccines market outlook. The market attractiveness is moderate to high, driven by increasing demand for vaccination programs and government initiatives. Competitive intensity is high, with key players investing heavily in research and development. The long-term outlook is positive, with a growing focus on innovation and technological advancements in vaccine development.

The innovation landscape is rapidly evolving, with a shift towards more effective and safer vaccines. Demand-supply balance is a key concern, with fluctuations in supply chains and manufacturing capacities. Key risk factors include regulatory changes, vaccine hesitancy, and emerging diseases. Overall, the Pediatric Vaccines market is expected to experience significant growth, driven by increasing awareness and investments in vaccine development.

11 items

1. Executive Summary

2. Pediatric Vaccines Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pediatric Vaccines Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pediatric Vaccines Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Newborn

6.1.2. Infant

6.1.3. Child

6.1.4. Dolescent

6.2. Global Pediatric Vaccines Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diphtheria

6.2.2. Influenza

6.2.3. Hepatitis

6.2.4. Pneumococcal Diseases

6.2.5. Meningococcal Diseases

6.2.6. Others

6.3. Global Pediatric Vaccines Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pediatric Vaccines Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pediatric Vaccines Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pediatric Vaccines Market Competition by Key Manufacturers

8.1. Global Pediatric Vaccines Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pediatric Vaccines: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. GlaxoSmithKline

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Merck

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Pfizer

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Sanofi

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. AstraZeneca

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Novartis

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Takeda Pharmaceutical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Bavarian Nordic

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Baxter

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. LG Life Sciences

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Lupin

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. S K Chemicals

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Mitsubishi Tanabe Pharma

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Janssen

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Shenzhen Kangtai Biological Products

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Sinovac Biotech

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Bharat Biotech

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Crucell

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Dynavax

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Serum Institute of India

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pediatric Vaccines Market

Figure 4: Global Pediatric Vaccines Market: Drivers

Figure 5: Global Pediatric Vaccines Market: Challenges

Figure 6: Global Pediatric Vaccines Market: Trends

Figure 7: Global Pediatric Vaccines Market: Opportunity

Figure 8: Global Pediatric Vaccines Market: Restraint

Figure 9: Global Pediatric Vaccines Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pediatric Vaccines Market Value (USD Million) By Region

Figure 15: Global Pediatric Vaccines Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pediatric Vaccines Market Value (USD Million) By Region

Figure 23: Global Pediatric Vaccines Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

93 items

Table 1: Market Segmentation Analysis

Table 2: Global Pediatric Vaccines Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pediatric Vaccines Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pediatric Vaccines Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pediatric Vaccines Market Value (USD Million) By Region

Table 10: Global Pediatric Vaccines Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pediatric Vaccines Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pediatric Vaccines Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pediatric Vaccines Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: GlaxoSmithKline Basic Information And Sales Area

Table 31: GlaxoSmithKline. Products Portfolio

Table 32: Merck Basic Information And Sales Area

Table 33: Merck. Products Portfolio

Table 34: Pfizer Basic Information And Sales Area

Table 35: Pfizer. Products Portfolio

Table 36: Sanofi Basic Information And Sales Area

Table 37: Sanofi. Products Portfolio

Table 38: AstraZeneca Basic Information And Sales Area

Table 39: AstraZeneca. Products Portfolio

Table 40: Novartis Basic Information And Sales Area

Table 41: Novartis. Products Portfolio

Table 42: Takeda Pharmaceutical Basic Information And Sales Area

Table 43: Takeda Pharmaceutical. Products Portfolio

Table 44: Bavarian Nordic Basic Information And Sales Area

Table 45: Bavarian Nordic. Products Portfolio

Table 46: Baxter Basic Information And Sales Area

Table 47: Baxter. Products Portfolio

Table 48: LG Life Sciences Basic Information And Sales Area

Table 49: LG Life Sciences. Products Portfolio

Table 50: Lupin Basic Information And Sales Area

Table 51: Lupin. Products Portfolio

Table 52: S K Chemicals Basic Information And Sales Area

Table 53: S K Chemicals. Products Portfolio

Table 54: Mitsubishi Tanabe Pharma Basic Information And Sales Area

Table 55: Mitsubishi Tanabe Pharma. Products Portfolio

Table 56: Janssen Basic Information And Sales Area

Table 57: Janssen. Products Portfolio

Table 58: Shenzhen Kangtai Biological Products Basic Information And Sales Area

Table 59: Shenzhen Kangtai Biological Products. Products Portfolio

Table 60: Sinovac Biotech Basic Information And Sales Area

Table 61: Sinovac Biotech. Products Portfolio

Table 62: Bharat Biotech Basic Information And Sales Area

Table 63: Bharat Biotech. Products Portfolio

Table 64: Crucell Basic Information And Sales Area

Table 65: Crucell. Products Portfolio

Table 66: Dynavax Basic Information And Sales Area

Table 67: Dynavax. Products Portfolio

Table 68: Serum Institute of India Basic Information And Sales Area

Table 69: Serum Institute of India. Products Portfolio

Table 70: Global Market Value (USD Million) (2025-2032) By Application

Table 71: Global Market Share (%) By Application (2032)

Table 72: Global Market Value (USD Million) (2025-2032) By Types

Table 73: Global Market Share (%) By Types (2032)

Table 74: Global Pediatric Vaccines Market Value (USD Million) By Region

Table 75: Global Pediatric Vaccines Market Share (%) By Region (2025-2032)

Table 76: North America Market Value (USD Million) (2025-2032) By Country

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: North America Market Value (USD Million) (2025-2032) By Types

Table 79: Europe Market Value (USD Million) (2025-2032) By Country

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Europe Market Value (USD Million) (2025-2032) By Types

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 85: South America Market Value (USD Million) (2025-2032) By Country

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: South America Market Value (USD Million) (2025-2032) By Types

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 91: Research Programs/Design For This Report

Table 92: Key Data Information From Secondary Sources

Table 93: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Pediatric Vaccines Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.60 million
Revenue forecast in 2033	27.40 million
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GlaxoSmithKline; Merck; Pfizer; Sanofi; AstraZeneca; Novartis; Takeda Pharmaceutical; Bavarian Nordic; Baxter; LG Life Sciences; Lupin; S K Chemicals; Mitsubishi Tanabe Pharma; Janssen; Shenzhen Kangtai Biological Products; Sinovac Biotech; Bharat Biotech; Crucell; Dynavax; Serum Institute of India
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Vaccine hesitancy and misinformation about vaccine safety can lead to decreased vaccination rates, negatively impacting the Pediatric Vaccines market size and public health outcomes.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Pediatric Vaccines Segmentation Breakdown12 items

Application

Newborn

Infant

Child

Dolescent

Types

Diphtheria

Influenza

Hepatitis

Pneumococcal Diseases

Meningococcal Diseases

Others

Regional Insights

Loading chart…

Competitive Landscape

GlaxoSmithKline: regional expansion

Merck: innovation pipeline

Pfizer: premium pricing

Sanofi: local manufacturing

AstraZeneca: OEM tie-ups

Novartis: vertical integration

Key Pediatric Vaccines Companies20 items

GlaxoSmithKline

Merck

Pfizer

Sanofi

AstraZeneca

Novartis

Takeda Pharmaceutical

Bavarian Nordic

Baxter

LG Life Sciences

Lupin

S K Chemicals

Mitsubishi Tanabe Pharma

Janssen

Shenzhen Kangtai Biological Products

Sinovac Biotech

Bharat Biotech

Crucell

Dynavax

Serum Institute of India

Market Ecosystem

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing vaccines

Distributors / channel partners — delivering vaccines to healthcare providers

Service providers / after-sales — offering vaccine administration and support

End users / buyers — healthcare providers and parents

Regulators/standards bodies — establishing vaccine safety and efficacy standards

Data/analytics providers — tracking vaccine effectiveness and epidemiological trends

Recent Industry Insights

Analyst Overview

Table of Contents